Centre Hospitalier Universitaire Dijon: Giant Cell Arteritis trials
The registry lists 11 Giant Cell Arteritis studies with Centre Hospitalier Universitaire Dijon as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)RecruitingNCT06609668
- TocilizuMab discontinuAtion in GIant Cell ArteritisActive, not recruitingNCT06037460Phase 3
- Evaluation of PET/CT of Cephalic Arteries for the Diagnosis of Giant Cell ArteritisCompletedNCT05246540
- COVID-19 Related Lockdown Effects On Chronic DiseasesCompletedNCT04390126
- MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled TrialActive, not recruitingNCT03892785Phase 3
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell ArteritisCompletedNCT03711448Phase 2
- Study of T Lymphocytes in Patients With Horton DiseaseStatus unknownNCT03313102Not applicable
- Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's DiseaseCompletedNCT02857192Not applicable
- Study of the T CD8 Immune Response in Horton's DiseaseCompletedNCT02158208
- Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)CompletedNCT02065297
- Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study.CompletedNCT01910038Phase 2